Jumawan, Baby Girl .
HRN: 26-69-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/22/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/22/2025
02/28/2025
IVT
40mg
OD
Sepsis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes